Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 0.00% is 100% below its 5-year average of 24.25%, near the high end of its 5-year range (-422.09%–100.00%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
-1.62%
GROSS MARGIN AVG 5Y
24.25%
GROSS MARGIN AVG 10Y
54.42%
GROSS MARGIN AVG 15Y
62.66%
GROSS MARGIN AVG 20Y
46.86%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+100.00%
CURRENT VS 5Y AVG
-100.00%
CURRENT VS 10Y AVG
-100.00%
CURRENT VS 15Y AVG
-100.00%
CURRENT VS 20Y AVG
-100.00%
SECTOR MEDIAN · HEALTHCARE
42.91%
median of 560 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Capricor Therapeutics, Inc.
Market Cap
$434.84M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
-1.62%
5Y Avg
24.25%
Market Cap
$432.00M
Gross Margin
100.00%
TTM Avg
-208.30%
3Y Avg
-64.13%
5Y Avg
-41.74%
Market Cap
$443.61M
Gross Margin
99.82%
TTM Avg
1.85%
3Y Avg
-144.74%
5Y Avg
-84.51%
Market Cap
$457.20M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$412.14M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
12.37%
Market Cap
$411.45M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$460.20M
Gross Margin
42.92%
TTM Avg
41.39%
3Y Avg
40.24%
5Y Avg
40.24%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Capricor Therapeutics, Inc. (CAPR) | $434.84M | 0.00% | 0.00% | -1.62% | 24.25% |
| Editas Medicine, Inc. (EDIT)vs › | $432.00M | 100.00% | -208.30% | -64.13% | -41.74% |
| Assembly Biosciences, Inc. (ASMB)vs › | $443.61M | 99.82% | 1.85% | -144.74% | -84.51% |
| Carlsmed, Inc. (CARL)vs › | $412.76M | 76.63% | 74.56% | 73.66% | 73.66% |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $457.20M | 0.00% | 0.00% | 0.00% | 0.00% |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $412.14M | 0.00% | 0.00% | 0.00% | 12.37% |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $411.45M | 0.00% | 0.00% | 0.00% | 0.00% |
| NeoGenomics, Inc. (NEO)vs › | $460.20M | 42.92% | 41.39% | 40.24% | 40.24% |
| Kamada Ltd. (KMDA)vs › | $460.98M | 40.82% | 42.91% | 40.22% | 37.63% |
| Shoulder Innovations, Inc. (SI)vs › | $408.54M | 77.34% | 76.74% | 77.57% | 77.57% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | -30.77% |
| 2024-09-30 | -422.09% |
| 2024-06-30 | -214.87% |
| 2024-03-31 | -126.23% |
| 2023-12-31 | 17.77% |
| 2023-09-30 | 100.00% |
| 2023-06-30 | 100.00% |
| 2023-03-31 | 100.00% |
| 2022-12-31 | 100.00% |
| 2022-09-30 | 100.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 100.00% |
| 2021-03-31 | 100.00% |
| 2020-12-31 | -4646.85% |
| 2020-09-30 | -15491.93% |
| 2020-06-30 | -3765.46% |
| 2020-03-31 | -522.08% |
| 2019-12-31 | -273.14% |
| 2019-09-30 | 100.00% |
| 2019-06-30 | 89.50% |
| 2019-03-31 | 100.00% |
| 2018-12-31 | 100.00% |
| 2018-09-30 | 100.00% |
| 2018-06-30 | 100.00% |
| 2018-03-31 | 100.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 100.00% |
| 2017-06-30 | 100.00% |
| 2017-03-31 | 100.00% |
| 2016-12-31 | 100.00% |
| 2016-09-30 | 100.00% |
| 2016-06-30 | 100.00% |
| 2016-03-31 | 100.00% |
| 2015-12-31 | 100.00% |
| 2015-09-30 | 144.27% |
| 2015-06-30 | 141.64% |
| 2015-03-31 | 171.59% |
| 2014-12-31 | -58.58% |
| 2014-09-30 | -63.82% |
| 2014-06-30 | 100.00% |
| 2014-03-31 | 100.00% |
| 2013-12-31 | 0.01% |
| 2013-09-30 | 100.00% |
| 2013-06-30 | 100.00% |
| 2013-03-31 | 100.00% |
| 2012-12-31 | 579.76% |
| 2012-09-30 | 35.49% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 100.00% |
| 2011-12-31 | 100.00% |
| 2011-09-30 | 100.00% |
| 2011-06-30 | 100.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 100.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 0.00% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | 0.00% |
| 2003-12-31 | 0.00% |
| 2003-09-30 | 100.00% |
| 2003-06-30 | 0.00% |
| 2003-03-31 | 0.00% |
| 2002-12-31 | 0.00% |
| 2002-09-30 | 0.00% |
